<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00725673</url>
  </required_header>
  <id_info>
    <org_study_id>M07-1752</org_study_id>
    <secondary_id>18223</secondary_id>
    <nct_id>NCT00725673</nct_id>
  </id_info>
  <brief_title>Case Control Study: Determinants of Osteoporosis in GOLD II COPD Patients.</brief_title>
  <official_title>Determination of Risk Factors for Developing Osteoporosis in COPD GOLD II Patients. A Case Control Study to Identify Possible Risk Factors for Developing Osteoporosis in COPD GOLD II Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Catharina Ziekenhuis Eindhoven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Catharina Ziekenhuis Eindhoven</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with COPD have been found to have an increased risk of osteoporosis. The underlying&#xD;
      mechanism is not clear yet. This case control study aims to identify risk factors for&#xD;
      osteoporosis in GOLD II COPD patients. COPD GOLD II patients with osteoporosis (cases) will&#xD;
      be matched by gender and age to COPD GOLD II patients without osteoporosis(controls).&#xD;
&#xD;
      Possible risk factors for osteoporosis are:&#xD;
&#xD;
        -  BMI/VVMI (body composition)&#xD;
&#xD;
        -  emphysema vs chronic bronchitis&#xD;
&#xD;
        -  physical capacity&#xD;
&#xD;
        -  Use of certain medication (eg corticosteroids, SSRI's)&#xD;
&#xD;
        -  Nutritional status&#xD;
&#xD;
        -  Infectious parameters Outpatients from the pulmonary ward of the Catharina Hospital&#xD;
           Eindhoven with GOLD II COPD according to the ATS and GOLD-guidelines will be included in&#xD;
           the study (after written informed consent).&#xD;
&#xD;
      A DEXA-scan will be made, if patients are osteoporotic or have a normal BMD they will be&#xD;
      included in the study.&#xD;
&#xD;
      A HRCT will be made, a six minutes walking distance will be performed, blood will be drawn&#xD;
      for lab. analysis, an X-ray of the vertebral collum will be made, impedance will be measured&#xD;
      and hight and weight will be measuered. Also patients will fill in a questionaire.&#xD;
&#xD;
      By univariate and multivariate analysis the collected data will be analysed to determine&#xD;
      possible risk factors for th development of osteoporosis in COPD GOLD II patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">June 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Risk factors for osteoporosis in GOLD II COPD patients</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">106</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>GOLD II COPD patients with osteoporosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>GOLD II COPD patients with a normal bone mineral density</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        GOLD II COPD patients (ATS and GOLD guidelines) visiting the outpatient clinic of pulmonary&#xD;
        medicine of the Catharina Hospital Eindhoven.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;= 40 years&#xD;
&#xD;
          -  GOLD II COPD&#xD;
&#xD;
          -  Written permission&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age &lt; 40 years&#xD;
&#xD;
          -  No COPD or COPD GOLD I, III or IV&#xD;
&#xD;
          -  no written permission&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lidwien Graat-Verboom</last_name>
    <role>Principal Investigator</role>
    <affiliation>Catharina Ziekenhuis Eindhoven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Catharina Hospital Eindhoven</name>
      <address>
        <city>Eindhoven</city>
        <state>Noord-Brabant</state>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <study_first_submitted>July 28, 2008</study_first_submitted>
  <study_first_submitted_qc>July 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2008</study_first_posted>
  <last_update_submitted>November 9, 2009</last_update_submitted>
  <last_update_submitted_qc>November 9, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2009</last_update_posted>
  <responsible_party>
    <name_title>L. Graat-Verboom/drs</name_title>
    <organization>Catharina Hospital Eindhoven</organization>
  </responsible_party>
  <keyword>COPD</keyword>
  <keyword>Osteoporosis</keyword>
  <keyword>BMD</keyword>
  <keyword>DEXA-scan</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

